The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Systemic therapy for advanced appendiceal adenocarcinoma: An analysis from the National Comprehensive Cancer Network (NCCN) database.
Mohamedtaki Abdulaziz Tejani
No relevant relationships to disclose
Anna ter Veer
No relevant relationships to disclose
Dana Milne
No relevant relationships to disclose
Rebecca Ottsesen
No relevant relationships to disclose
Tanios S. Bekaii-Saab
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech
Honoraria - Amgen; Bristol-Myers Squibb; Genentech
Al Bowen Benson
No relevant relationships to disclose
Deborah Schrag
No relevant relationships to disclose
Stephen Shibata
No relevant relationships to disclose
John Michael Skibber
No relevant relationships to disclose
Martin R. Weiser
No relevant relationships to disclose
Neal W. Wilkinson
No relevant relationships to disclose
Steven J. Cohen
Honoraria - Genentech
Research Funding - Genentech